A Free Service Provided By



Legal Topics

Arbitration and Mediation
Car Accidents
Child Support
Child Custody & Visitation

Copyright Law
Criminal Law
Dangerous Drugs
DUI Drunk Driving

Elderly Laws
Employees' Rights
Estate Planning
Family Law
Immigration Law

Lemon Law
Medical Malpractice
Megan's Law
Mesothelioma & Asbestos

Probate & Estates
Product Recalls
Real Estate

Statute of Limitations

Taxes & the IRS
Traffic Violations
Workers' Compensation
Work Related Injury

Privacy Policy

Contact Us

About Us

Facts - Books - News    U.S. Facts Of Law:

Vioxx, FDA Health Advisory - Sept 30, 2004

On September 30, 2004, and FDA Health Advisory was issued announcing that Merck was announcing a voluntary withdrawal of Vioxx from the market due to safety concerns.  Vioxx was a commonly prescribed drug in the non-steroidal anti-inflammatory drug (NSAID) family.  It was approved by the FDA in 1999 for the management of pain and inflammation and was widely prescribed to arthritis sufferers.

A long term study of Vioxx on patients suffering from recurrent colon polyps was stopped early in September 2004 for safety reasons.  Subjects of the study using Vioxx showed an increased risk of heart attack and stroke compared to subjects taking a placebo.  Merck voluntarily pulled Vioxx from the market on September 30th.


Vioxx FDA Health Advisory Best Sellers from

(no title)


Newsfeed display by CaRP

Vioxx FDA Health Advisory News
GN News

Surprise Arthritis Drug Celebrex Shown As Safe As Ibuprofen And Naproxen Forbes
Forbes Surprise Arthritis Drug Celebrex Shown As Safe As Ibuprofen And Naproxen Forbes Merck immediately withdrew Vioxx from the market. However, the FDA was in a To help with this problem, the FDA called a joint meeting of their Arthritis Advisory Committee and the Drug Safety amp Risk Management Advisory Committee. This meeting Celebrex Is Found to Be No Riskier for Hearts Than Other Pain DrugsNew York Times all 216 news articles raquo

Puma Biotechnology FDA Live Blog Forbes
Forbes Puma Biotechnology FDA Live Blog Forbes 8:10 AM: First up, the opening remarks by Laleh Amiri Kordestani, MD, the medical team leader for the group that reviews breast cancer drugs at the FDA. The tenor of her remarks could predict what will happen at this meeting. She reviews the results Puma Biotechnology Inc PBYI Stock Price Today ZacksZacks Investment Research bryce richard paul eyler charles r all 145 news articles raquo

AposTough As Nailsapos: Storm Swirls Around FDA Drug Cop Who Approved Controv...
STAT 39Tough as nails39: Storm swirls around FDA drug cop who approved controversial drug STAT She also had to stand up to criticism that the FDA moved too slowly on Vioxx, a painkiller which led to heart attacks and strokes in adults. Manufacturer Merck ultimately took it off the market. She has been in this position two decades now, said Dr

Puma Biotech Shares Are Roaring On An FDA Review. Hereaposs What Could Still ...
Forbes Puma Biotech Shares Are Roaring On An FDA Review. Here39s What Could Still Go Wrong Forbes The reason: an advisory panel for the Food and Drug Administration will review the company39s breast cancer drug, neratinib, at a half day meeting Wednesday morning. Today, the FDA staff posted briefing documents that will be used by the experts on the and more raquo

FDA Officially Belongs To Big Pharma With Senate Confirmation Of Dr. Robert C...
EcoWatch FDA Officially Belongs to Big Pharma With Senate Confirmation of Dr. Robert Califf EcoWatch It is hard to believe only four senators opposed the confirmation of Robert Califf, who was approved Wednesday as the next Food and Drug Administration FDA commissioner. Vocal opponent Bernie Sanders condemned the vote from the campaign trail. U.S. Senate: U.S. Senate Roll Call Votes 114th Congress 2nd SessionUS Senate Margaret Hamburg WikipediaWikipedia all 301 news articles raquo

IMPORTANT NOTICE: This webpage is Copyrighted content.  No portion of this page may be copied to any other webpage, forum, blog or other domain page or offline publication without written permission from Violators will be prosecuted to the fullest extent of the law.

The information provided by does not constitute legal advice or any other type of advice and is provided for educational purposes only without warranty of any kind. has not reviewed the information on this page for accuracy and is not responsible for any errors, omissions or inaccuracies.  For legal advice you should consult a licensed attorney.


Copyright All Rights Reserved -
No Portion of This Page May Be Copied Without Written Permission

Facts of Law about the vioxx fda health advisory

Facts of Law - Vioxx FDA Health Advisory